The confusion surrounding the COVID-19 vaccine caused by the suspension of its supply to Europe has affected the vaccination schedule in our country. Pfizer informed about production limitation due to modernisation of production lines, which affected Monday’s delivery. At the moment, it is known that the Polish producer of medicines – Polfa Tarchomin – is…
The first COVID-19 vaccination in Poland was carried out on 27 December. Within two and a half weeks, nearly 260,000 people had already been vaccinated, 37 of whom had adverse post-vaccination reactions (NOP). It is for some of these that a Compensation Fund is to be set up, the Minister of Health announced yesterday. More…
GPs will get support. Because the Home Care Program has been launched to help them supervise patients with confirmed COVID-19 infection. Importantly, the program will automatically cover people with COVID-19 who are over 55 years old and remain in home isolation. What about the others? PZU Zdrowie doctors involved in the program The Ministry of…
The California-based company Lucira Health received the first FDA approval to market the COVID-19 test to be performed by a patient at home. The result is to be known after only 30 minutes. This is to speed up the diagnosis of COVID-19 patients significantly. Approval of Lucira COVID-19 All-In-One Test Kit by FDA Lucira Health…
The European Commission (EC) announced at the end of last week that it had signed a contract to purchase 400 million doses of COVID-19 vaccine. The contract was signed with AstraZeneca. The value of the contract has not been disclosed. It is only known that the EC paid an advance of EUR 336m. Vaccine purchase…
Are we approaching a breakthrough in the development of a vaccine for the coronavirus causing COVID-19 disease? Another company informed about the results of the first phase of clinical trials. The vaccine developed by the biotechnological company Moderna Therapeutics is causing an immunological response. However, it will be subjected to further testing. COVID-19 vaccine –…
The U.S. pharmaceutical company Pfizer announced in a statement that the first test of COVID-19 vaccine developed in cooperation with the German biotechnology company BioNTech has been completed. Currently, there are four types of Pfizer vaccine for Sars-Cov-2 in the testing phase. One of them will be commercially available. World: ongoing work on COVID-19 vaccine…
In the United States, the first human clinical trials of a potential coronavirus vaccine have already begun. It was developed by the biotechnological company Moderna Therapeutics. From sequence to vaccine testing in 63 days Due to the high epidemiological risk and the progressing pandemic, work on vaccines and, possibly, drugs for coronavirus is progressing at…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.